These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 42953)

  • 1. [Modification of the action of drugs by inhibition of their metabolism].
    Park BK; Breckenridge AM; Ohnhaus EE
    Recenti Prog Med; 1979 Sep; 67(3):313-45. PubMed ID: 42953
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enzyme induction in the liver changes drug activity].
    Greim H
    Med Klin; 1980 Sep; 75(20):709-12. PubMed ID: 6999314
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of the induction and repression of the enzymes of drug metabolism].
    Bushma MI; Lukienko PI
    Klin Med (Mosk); 1982 May; 60(5):16-21. PubMed ID: 7109509
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical implications of enzyme induction and enzyme inhibition.
    Park BK; Breckenridge AM
    Clin Pharmacokinet; 1981; 6(1):1-24. PubMed ID: 6113907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicin.
    Ohnhaus EE; Kirchhof B; Peheim E
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):591-7. PubMed ID: 35298
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man.
    Gachályi B; Tornyossy M; Vas A; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):133-5. PubMed ID: 6103880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of hepatic drug-metabolizing enxyme activity in man. Comparison of three different assays.
    Sotaniemi EA; Pelkonen RO; Puukka M
    Eur J Clin Pharmacol; 1980 Apr; 17(4):267-74. PubMed ID: 6105079
    [No Abstract]   [Full Text] [Related]  

  • 8. Enzyme induction and medical treatment.
    Hunter J
    J R Coll Physicians Lond; 1974 Jan; 8(2):163-74. PubMed ID: 4810112
    [No Abstract]   [Full Text] [Related]  

  • 9. Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.
    Ohnhaus EE; Park BK
    Eur J Clin Pharmacol; 1979 Mar; 15(2):139-45. PubMed ID: 35353
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug interactions between glucocorticoids and other drugs].
    Kawai S; Ichikawa Y
    Nihon Rinsho; 1994 Mar; 52(3):773-8. PubMed ID: 8164381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings of the fourth Deer Lodge Conference on Clinical Pharmacology: Environmental chemicals and nutrition--relationship to metabolism, action, and toxicity of drugs: concluding remarks.
    Dollery CT
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 2):823-4. PubMed ID: 913038
    [No Abstract]   [Full Text] [Related]  

  • 12. [Place of gammaglutamyltransferase among the indirect procedures of evaluation of the function of enzymes of drug metabolism (author's transl)].
    Siest G; Ratanasavanh D; Bagrel D; Tazi A; Galteau MM
    Ann Biol Clin (Paris); 1980; 38(1):67-73. PubMed ID: 6103683
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between changes in drug score, D-glucaric acid excretion, and gamma-glutamyltransferase and beta-glucuronidase serum activities during anticonvulsant treatment.
    Hermida J; Fernández MP; Tutor JC
    Clin Lab; 2002; 48(7-8):415-9. PubMed ID: 12146576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the drug metabolism capacity of the liver.
    Park BK
    Br J Clin Pharmacol; 1982 Nov; 14(5):631-51. PubMed ID: 6128018
    [No Abstract]   [Full Text] [Related]  

  • 15. Research on the eventual enzymatic induction activity of cetiedil in rat and man.
    Larousse C; Kergueris MF; Le Normand Y; Visset J
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):195-9. PubMed ID: 7390670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the effect of drugs due to reciprocal interference with their protein binding and catabolism].
    Remmer H
    Dtsch Med Wochenschr; 1974 Mar; 99(9):413-9. PubMed ID: 4857236
    [No Abstract]   [Full Text] [Related]  

  • 17. [Induction and inhibition of drug-metabolizing enzymes. Significance for pharmacotherapy, toxicity and clinical testing].
    Rugstad HE
    Tidsskr Nor Laegeforen; 1969 Feb; 89(3):172-6. PubMed ID: 5795436
    [No Abstract]   [Full Text] [Related]  

  • 18. Brain uptake of metabolites and drugs following carotid arterial injections.
    Oldendorf WH
    Trans Am Neurol Assoc; 1971; 96():46-50. PubMed ID: 4400654
    [No Abstract]   [Full Text] [Related]  

  • 19. Note on the enzyme assay for urinary D-glucaric acid and correlation with rifampicin-induced mixed function oxidase activity.
    Perry W; Jenkins MV
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):609-13. PubMed ID: 3793294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History of drug metabolism: the first half of the 20th century.
    Bachmann C; Bickel MH
    Drug Metab Rev; 1985-1986; 16(3):185-253. PubMed ID: 3914936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.